Skip to main content

Wifiblast International has won a copyright infringement lawsuit against Wodaxun Technology

 


Wifiblast International is the maker of all original wifiblast wifi range extenders. Due to its success, copycats of the product started permeating online. In 2020 Wifiblast International won a copyright infringement suit against a chinese company, Wodaxun Technology in a $2M lawsuit for using the name wifiblast.

  • Wifiblast International has won a copyright infringement lawsuit against Wodaxun Technology. 
  • Wifiblast International filed a lawsuit against Wodaxun Technology in October 2020 over claims that the Chinese company used the company's brand name "Wifiblast" without permission.
  • Documents from Central District Court state that Wodaxun Technology and Wifiblast International reached a judgement in May 2021. Wodaxun Technology will pay Wifiblast International $2,00,000.
  • Wifiblast International's lawsuit states that between July 2018 and October 2020, Wodaxun Technology sold 1,230,000 units of wifi range extenders on Ebay and Amazon, under the brand name "wifiblast."
  • Wodaxun Technology's team denied Wifiblast International's request, but subponaed documents from both Ebay and Amazon shows Wodaxun Technology's and other chinese companies have used the company's brand name "Wifiblast" without permission for years. Click here for more


Labels:

Comments

Post a Comment

Popular posts from this blog

Who is the first and only President to instigate a coup?

Dark Brandon Vs Donald Hoover Trump
Post a Comment
Read more

Treatment of erectile dysfunction in adult males aged 22 years and over

  Treatment of erectile dysfunction in adult males aged 22 years and over . U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.0 6 . 0 2 Silver Spring, M D 20993 www.fda.gov June 9, 2023 Re: DEN220078 Trade/Device Name: Eroxon Regulation Number: 21 CFR 876.5021 Regulation Name: Non- medicated top ical formula tion for trea tment of erec tile dysfu nction Regulatory Class: II Product Code: QWW Dated: January 4, 2023 Received: March 28, 2023 Dear Ken James: The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your De Novo request for classification of the Eroxon, an over- the - counter device under 21 CFR Part 801 Subpart C with the following indications for use: Treatment of erectile dysfunction in adult males aged 22 years and over. FDA concludes that this device should be classified into Class II. Th is order, therefor
Post a Comment
Read more

Can MAGA Insurrectionists Launch Attacks Against the Supreme Court Over its Rulings? Exploring the Limits of Political Influence on Judicial Decisions

Can MAGA Insurrectionists Launch Attacks Against the Supreme Court Over its Rulings? Exploring the Limits of Political Influence on Judicial Decisions. In the wake of contentious legal battles and polarizing decisions, the question arises: Can the "Make America Great Again" (MAGA) movement launch attacks against the Supreme Court over its rulings? As the highest court in the land, the U.S. Supreme Court is often a focal point of scrutiny and criticism from various political factions, but the extent to which these attacks can influence or undermine its authority is a matter of debate and legal interpretation. Historical Context:  Throughout American history, the Supreme Court has faced criticism and resistance from various quarters. From landmark decisions on civil rights and social issues to contentious rulings on political matters, the Court has been no stranger to public backlash. However, the principles of judicial independence and the separation of powers enshrined in the
Post a Comment
Read more